Tickr
Home Explore Daily Brief Market Watchlists Portfolio
Research
Catalysts Signal Factory Screener Market News Event Calendar Valuation Plot Heat Map Top Investors Industry Trends Options
AI Assistant Notifications Account
Atea Pharmaceuticals, Inc. logo

Atea Pharmaceuticals, Inc. (AVIR) Stock Ticker

NASDAQ: AVIR · Healthcare · Biotechnology
$5.17+0.00%
USD · as of 2026-09-28 · market cap $413.7M
Open AVIR in TickrDownload for iPhone

AVIR right now

Options price it to move more than 9 in 10 stocks.
Options expect by Oct 6±13.8%
Options expect by Oct 29±28.5%
Priced in for Nov 11 earnings±34.2%
IV rank (30-day)88% · rich
From Tickr's live models · 2026-09-29. Not investment advice.

Market factors today

Tickr 500 vs S&P 500+0.49%+1.0% MTD
Momentum L/S+1.35%+15.1% MTD
High-beta momo L/S+1.46%+22.2% MTD
Rate sensitivity L/S+1.91%+6.9% MTD
Oil sensitivity L/S-2.54%-5.3% MTD
Unprofitable tech-1.43%+3.7% MTD

Unlock the full AVIR picture

🔒 Implied move chart & probabilities
🔒 Live options flow
🔒 AI analysis & chat on AVIR
🔒 Catalysts & earnings
🔒 Strategy Lab
🔒 Financials & estimates
Start your 7-day free trial

About Atea Pharmaceuticals, Inc.

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in Phase 3 clinical trial for the treatment of hepatitis C virus (HCV). The company also developing AT-587, that is in Phase 1 clinical trial for the treatment of chronic HEV infection. In addition, it offers a proprietary platform of nucleosides and nucleotides for virology, medicinal chemistry, and antiviral drug development. The company has a license agreement with MSD International GmbH for the development, manufacture, and commercialization of ruzasvir. Atea Pharmaceuticals, Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts.

AVIR stock facts

Ticker symbolAVIR
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
Market cap$413.7M
CEOJean-Pierre Sommadossi
Employees55
HeadquartersBoston, MA, US
IPO date2020-10-30
Websitewww.ateapharma.com

What you can see for AVIR on Tickr

Live AVIR price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the AVIR report.

Rankings

Largest Healthcare companiesLargest companies by market cap

FAQ

What is the ticker symbol for Atea Pharmaceuticals, Inc.?

The ticker symbol for Atea Pharmaceuticals, Inc. is AVIR, listed on the NASDAQ.

What is AVIR?

Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes oral antiviral therapeutics for patients with serious viral infections. Its lead product candidate is the regimen of bemnifosbuvir, a nucleotide NS5B inhibitor, and ruzasvir, an NS5A inhibitor, which is in Phase 3 clinical trial for the treatment of hepatitis C virus (HCV). The company…

HomeExploreMarketLists
All pages